VARONIS SYSTEMS, INC. (VRNS): what the price assumes

In the published model solve dated 2026-Q2, anchored at $43.40, VARONIS SYSTEMS, INC. (VRNS) is priced for +23.9% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/VRNS

Headline

FieldValue
TickerVRNS
CompanyVARONIS SYSTEMS, INC.
Current price$43.40/sh
CompositionSaaS 74% / Term license subscriptions 18% / Maintenance and services 8%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisrevenue-multiple
EV / sales paid7.0x
Steady-state operating margin assumed31.5%
Implied growth23.9%

The company earns no operating profit yet; the inversion runs on the revenue multiple and an assumed steady-state margin.

Solve inputs: computed at a 9.8% cost of capital with 4% terminal growth over a 5-year stage, holding a 31.5% terminal operating margin (78.8% gross margin x the 40% mature-conversion prior); each 1pp of cost of capital moves the implied revenue growth ~7.3pp.

How unusual the bet is: within-range

ReferenceValue
vs own history-1.48σ
sustained it ~5 years at this level36%
implied end-window share0%

Valuation X-Ray

The price is justified by relative-multiple; asset-based/earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset11.84x2expensive
Earnings4.87x1expensive
Relative0.91x2justifies
Growth1.35x3expensive

Families that justify the price: Relative Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.7%); the inversion above states its own rate.

Per-Model Detail (n=8)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$32.091.35xyesFCF base $0.1B, growth 16% (input: historical growth), terminal g 4.0%, WACC 8.7%, 6yr projection
DCF Exit MultipleGrowth$0.00noNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelative$47.940.91xyesP/S fallback (negative EPS): Sector P/S 8.0x × TTM revenue — excluded from consensus
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$3.8711.21xyesBook value floor: BV/sh $3.87, ROE negative
Two-Stage Excess ReturnAsset$3.4812.47xyesBook value with convergence: BV/sh $3.87, ROE converges to ke
Discounted Future Market CapGrowth$40.831.06xyesRev $0.7B, growth 16% (input: historical growth; tapered), Terminal P/S: 5.9x / 7.2x / 8.6x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$0.00noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowth$23.681.83xyesMargin ramp: -21% → 22% over 7yr, rev growth 16% (input: historical growth; tapered)
Earnings Power ValueEarningsno
Residual IncomeAssetno
Graham NumberAssetno
EV/EBITDA RelativeRelativeno
FCF YieldEarnings$8.914.87xyesFCF $121.9M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarningsno
ROIC-Justified P/BAssetno
P/Sales SectorRelative$47.940.91xyesRevenue $0.69B × sector P/S 8.0x
PEG Fair ValueRelativeno
Earnings YieldEarningsno
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Varonis (consolidated)operatingenterprise0.6B reported-currencywithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net cash$206.8m
Share count CAGR (dilution)1.2%
Burning cashno

Operating profit is negative or near zero and the company has no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so years-to-repay cannot be computed honestly.

Operating profit is negative or near zero and there is no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so interest coverage cannot be computed honestly.

Bullet Takeaways

Bull Case

The balance sheet tells you this is a company funding its own transformation rather than betting the house on it. Varonis holds roughly $295 million of net cash and about $748 million of liquid assets, and it is generating free cash flow even as the income statement shows a GAAP loss, with management guiding to $100 million to $105 million of free cash flow this year. That gap matters: the reported operating loss is largely the accounting drag of converting term-license customers to SaaS plus heavy stock compensation, not a business that consumes cash. A company with net cash, positive and growing free cash flow, and no need to raise capital can run its model transition on its own terms, which is exactly the position Varonis is in.

The growth underneath is genuine and tied to a powerful theme. Total SaaS ARR reached $683.2 million in Q1 2026, up 69% year over year, and even excluding the one-time conversion uplift, SaaS ARR grew 29%, with management guiding to a sustainable 20% to 21% growth rate as it finishes moving to a fully SaaS model. Revenue rose 27% to $173.1 million, and full-year guidance was raised to SaaS ARR of $814 million to $845 million. The demand driver is AI: as companies rush to deploy AI on their own data, they have to know where sensitive data lives and who can reach it, and Varonis sits exactly at that control point, extending the platform with AI-security products like Atlas, including an integration that brings Claude Compliance API activity into the platform.

The valuation supports the case rather than fighting it. At about five times revenue, the price implies the business eventually earns an operating margin around 31% and grows roughly 10% a year, both of which look conservative against current ARR growth in the twenties and the high gross margins typical of security software. Varonis itself notes in its 10-K that revenue can swing meaningfully period to period purely because of the SaaS-conversion accounting, so the noisy reported top line understates the underlying recurring momentum. The Street is constructive, with 17 buy ratings and no sells, an average target in the low-to-mid forties, and the stock has also drawn takeover speculation. The bull case is a cash-generative, fast-growing data-security platform riding the AI-security wave, priced for far less growth than it is delivering.

Bear Case

The variable with the most leverage on this thesis is the IT-security budget cycle and the platform-consolidation pressure around it, and neither is reflected in a price that assumes smooth maturation. Data security is a category large platform vendors covet, and the most pointed risk is that the big suites, Microsoft chief among them with its native data-governance and security tooling, fold good-enough capability into products customers already pay for. When a buyer can get adequate data classification and monitoring bundled into an existing platform, a standalone specialist has to keep proving it is materially better to justify a separate line item. Recent Street research explicitly flags caution on how defendable Varonis's product set is as platforms consolidate, and that is the long-term question the current price does not discount.

The model transition itself carries execution risk that the GAAP statements make hard to read. Varonis is still unprofitable on a reported basis, with a trailing operating loss, and the two operating-income bases here diverge by more than 200%, a sign of how distorted the financials are mid-conversion. The company's own 10-K warns that revenue can vary significantly period to period because of the SaaS revenue-recognition treatment, which means a soft quarter can look worse, or a strong one better, than the underlying business warrants. An investor relying on the headline numbers can be whipsawed, and a transition that stalls, with conversions slowing or net retention slipping, would undercut the ARR growth the valuation leans on.

Macro and international exposure complete the risk picture. Security spending is resilient but not immune to broad IT-budget tightening, and a slowdown in enterprise software purchasing would pressure new-logo growth and expansion at the same time. The 10-K also notes that rest-of-world revenue growth has fluctuated and may continue to, based on the timing of deal closures, so the international piece adds lumpiness. The price embeds a 31% terminal operating margin the company has not yet demonstrated; if competition compresses pricing or the path to that margin proves slower, the valuation has to come down. The takeover speculation that has supported the stock is a double-edged catalyst, because if a deal does not materialize, some of that premium can unwind.

Valuation

Varonis is mid-transition and not yet earning a normal operating profit, so the price is set against sales rather than earnings. At $33.42 (June 28, 2026) the stock trades at about five times revenue, and the inversion shows that implies the business eventually reaches an operating margin around 31% and grows revenue roughly 10% a year over the next several years. The reliability on this solve is reasonable, and the implied assumptions are notably undemanding next to reality: SaaS ARR is growing 29% excluding conversions and the company guides to a sustainable 20% to 21%, well above the 10% the price embeds.

The X-ray frames the price as justified by the right methods. The relative-multiple and growth-DCF families support the quote, while the asset-based and earnings-power families say expensive, which is exactly what you expect for a high-growth software company: it is not cheap on assets or trailing earnings, but it is reasonable against peers and against a forward-growth view. The key adjustment is to look past the GAAP loss to free cash flow, guided at $100 million to $105 million this year, which is the real cash the business throws off once the conversion accounting is set aside.

The honest synthesis is that the valuation is reasonable-to-attractive if the SaaS transition completes and the AI-security demand holds. The price asks for 10% growth and a 31% margin; the company is growing ARR twice that fast and security software routinely reaches margins in that range at scale. The risk is not the entry multiple but durability: whether platform consolidation, led by the large suites, erodes the standalone case before Varonis reaches the implied margin. The analyst consensus, a buy with an average target in the low-to-mid forties and no sell ratings, leans toward the constructive read. The conclusion is a business priced for modest outcomes that is currently delivering better than modest, with the debate centered on competitive defensibility rather than on whether the price is stretched.

Catalysts

The recurring catalyst is SaaS ARR growth and the completion of the model transition. Q1 2026 showed total SaaS ARR of $683.2 million, up 69% year over year and 29% excluding conversions, with revenue up 27% to $173.1 million, and SaaS now about 86% of ARR on the way to 100% by the end of calendar 2026. Management raised full-year guidance to SaaS ARR of $814 million to $845 million and free cash flow of $100 million to $105 million, so the key checkpoints are whether ARR growth ex-conversions holds in the 20s and whether free cash flow tracks the guide.

The product and demand catalyst is AI security. Varonis launched its Atlas AI Security Platform and announced an integration bringing Claude Compliance API activity into it, alongside traction in managed data detection and response, database activity monitoring, and Interceptor. As enterprises deploy AI on their own data, the need to govern and secure that data is the structural tailwind, so uptake of these newer products is the leading indicator of durable growth.

Two external threads frame the rest. The competitive dynamic, especially platform consolidation by large security and productivity suites, is the swing factor for long-term defensibility, and any sign of pricing pressure or share loss would weigh on the multiple. The other thread is corporate action: the stock has drawn takeover speculation, so any concrete development on a potential sale would move it sharply, while the absence of one could unwind part of the speculative premium. The analyst consensus is a buy with an average target in the low-to-mid forties.

Peer Cohorts (Per Segment, With Filing Citations)

Varonis (consolidated) (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive VRNS report on boothcheck